March 4, 2026
Setup$Custom
Monthly$Custom/mo
Setup$Custom
Monthly$Custom/mo
Nabla Bio enables pharmaceutical and biotech companies to bring more antibody therapies to patients. By leveraging AI and massively parallel experimentation, Nabla Bio designs antibodies that precisely bind to disease targets at the optimal location, while minimizing manufacturability and toxicity risks. The company comprises a bilingual team of wet- and dry-lab scientists, with expertise in AI and protein design.
This listing was created by AgentSquare from publicly available information.
What happens next: We'll share your details with the Vendor team and introduce you. No commitment.
Listed By
AgentSquare
This profile was created by AgentSquare based on publicly available information to help buyers discover AI agents. It is not managed by the vendor. Information may be incomplete.
Are you behind this agent?
Sign in to Claim